Should FDG-PET imaging be considered on a routine basis in clinical trials for carcinoma of esophagus to assure uniformity of protocols among sites?

Eur J Nucl Med Mol Imaging. 2007 Apr;34(4):604-5. doi: 10.1007/s00259-006-0315-z.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma / diagnostic imaging*
  • Carcinoma / pathology
  • Clinical Trials as Topic / standards*
  • Esophageal Neoplasms / diagnostic imaging*
  • Esophageal Neoplasms / pathology
  • Fluorodeoxyglucose F18*
  • Guidelines as Topic*
  • Humans
  • Positron-Emission Tomography / standards*
  • Quality Assurance, Health Care / methods
  • Quality Assurance, Health Care / standards*
  • Radiography
  • Radiopharmaceuticals

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18